NGS in Agrigenomics Market Insights

Global NGS in Agrigenomics market size was valued at USD 820 million in 2025. The market is forecasted to rise from USD 860 million in 2026 to USD 1.42 billion by 2034, reflecting a CAGR of approximately 6.5% during the forecast period.

Next‑Generation Sequencing applied to agrigenomics encompasses high‑throughput DNA sequencing technologies that enable rapid decoding of plant and animal genomes for breeding, trait discovery, and disease resistance studies. By delivering dense marker data and whole‑genome insights, NGS accelerates genomic selection pipelines and supports precision agriculture initiatives.

📥 Download FREE Sample Report:
NGS in Agrigenomics Market - View in Detailed Research Report

The market is expanding because agricultural biotech firms are allocating larger budgets toward molecular breeding tools, while regulatory frameworks encourage the adoption of data‑driven crop improvement strategies. Moreover, continuous enhancements in sequencing chemistry and cost reductions make large‑scale projects financially viable. For example, in March 2024 Illumina announced a strategic partnership with Bayer to co‑develop a customized sequencing platform aimed at accelerating cereal crop improvement programs. Companies such as Thermo Fisher Scientific, AgriSeq Solutions, and New England Biolabs maintain extensive portfolios that address library preparation, data analysis, and downstream validation needs.

Key Market Drivers

Rising Demand for Precision Breeding
The agricultural sector is embracing genomic‑guided selection to accelerate trait development. Breeders now rely on high‑throughput DNA sequencing to identify disease‑resistant alleles, reducing cycle time from years to months. This shift fuels adoption of next‑generation sequencing platforms across research institutes and private seed companies.

Advancements in Sequencing Technology
Recent enhancements in read length, accuracy, and reagent cost have lowered the economic barrier for routine agrigenomic projects. Instruments that once required multi‑million‑dollar investments now offer pay‑per‑sample models, making large‑scale genotyping feasible for midsized farms. The technology’s scalability directly catalyzes market expansion.

➤ Analysts note that the convergence of cheaper consumables and cloud‑based analytics is reshaping the competitive landscape, prompting legacy vendors to accelerate product roadmaps.

Market Challenges

Data Integration Hurdles
Although raw sequencing output is abundant, transforming reads into actionable breeding decisions requires robust pipelines that can merge genotype, phenotype, and environmental datasets. Many organizations lack the internal expertise to curate such multidimensional information, resulting in delayed implementation of selection strategies.

Regulatory Uncertainty
Policies governing the release of genomically informed cultivars vary widely across regions. Ambiguous guidelines on data privacy and intellectual property can deter investors from committing resources to large‑scale NGS projects.

Market Restraints

High Up‑Front Capital Expenditure
Acquiring state‑of‑the‑art sequencers, establishing clean‑room facilities, and training personnel represent sizable financial commitments. For many agribusinesses operating on thin margins, the initial outlay outweighs short‑term returns, prompting a cautious rollout of sequencing programs.

Market Opportunities

Emerging Applications in Climate‑Resilient Crops
Climate variability is compelling growers to seek varieties that tolerate heat, drought, and salinity. NGS enables rapid identification of alleles linked to stress tolerance, opening a revenue stream for service providers that can deliver custom marker panels. Companies that align their portfolios with these breeding objectives are positioned to capture a growing share of the agrigenomics spend.

Key Statistics:

2025 Market Size

USD 820 million

2034 Projected Market Size

USD 1.42 billion

CAGR (2025–2034)

6.5%

Largest Market in 2025

North America

Key Takeaways: NGS in Agrigenomics Market

• USD 820 million recorded in 2025 provides a solid platform for expansion.

• USD 1.42 billion projected for 2034 translates into more than a seventy‑percent uplift over nine years.

• 6.5% CAGR underscores steady uptake of sequencing across breeding pipelines.

• North America remains the dominant region, buoyed by deep research networks and strong venture funding.

• Whole‑genome sequencing commands the largest sub‑segment as breeders prioritize unbiased variant discovery for complex traits.

Analyst Note

The sector benefits from a cascade of cost cuts in reagents and instrument depreciation, turning large‑scale projects into financially sensible choices for midsized seed firms. While capital outlay for cutting‑edge sequencers still deters some adopters, cloud‑based bioinformatics services are lowering the barrier to entry and spawning new revenue streams for service providers. Companies that can stitch together genotype data with emerging phenotyping platforms stand to accelerate breeding cycles dramatically, delivering tangible yield improvements that resonate with both investors and growers.

SEGMENT ANALYSIS

COMPETITIVE LANDSCAPE

NGS‑Enabled Agrigenomics: Competitive Overview

Illumina, Thermo Fisher Scientific, and BGI are the dominant forces shaping the NGS agrigenomics arena. Illumina’s NovaSeq platform, coupled with a robust partner ecosystem for plant‑specific library kits, anchors its market leadership. Thermo Fisher leverages the Scale‑up instrument family and a global service network to capture large breeding programs, while BGI offers cost‑competitive sequencers that appeal to price‑sensitive research institutions in emerging economies.

Beyond the triad, niche players enrich the ecosystem. Oxford Nanopore Technologies provides portable MinION devices enabling field‑based genotyping. Roche’s SeqCap and AgriGenomics’ targeted capture solutions address trait‑focused pipelines. PerkinElmer and Eurofins deliver bio‑informatics services that translate raw reads into actionable markers. Start‑ups such as GeneArt and AgriBioTech specialize in rapid assay development for disease resistance, often co‑developing customized panels with breeding consortia.

List of Key Agrigenomics Companies Profiled

• Illumina

• Thermo Fisher Scientific

• BGI Group

• Oxford Nanopore Technologies

• Roche Sequencing Solutions

• PerkinElmer

• Eurofins Genomics

• AgriGenomics

• GeneArt

• AgriBioTech

• Pacific Biosciences

• Syngenta Crop Genetics

MARKET TRENDS

Rising Cost Competitiveness Accelerates Adoption

Sequencing reagents and instrument depreciation costs have fallen by roughly 40 % over the past year, bringing per‑sample expenses within reach of midsized seed firms and university programs. The shift is prompting many laboratories to repatriate workflows in‑house, shrinking turnaround times from weeks to days and fostering direct hiring of bioinformatic talent.

Synergy with Digital Phenotyping Platforms

High‑resolution imaging and sensor networks now enable genotype‑to‑phenotype matching at field scale. Early adopters report breeding‑cycle reductions of up to 20 % by eliminating redundant field trials and focusing resources on genetically promising lines.

Regulatory Alignment Enhances Data Sharing

Harmonized data‑privacy guidelines across major agricultural jurisdictions have lowered legal friction for cross‑border collaborations. Standardized repositories accelerate joint breeding initiatives and expand the genetic diversity pool available for elite cultivar development.

REGIONAL ANALYSIS

North America
North America leads the market, powered by a mature research ecosystem, significant private‑sector investment, and a regulatory climate that encourages genomic innovation. Federal grants and venture capital fuel startups that integrate sequencing with advanced phenotyping, while large agro‑chemical corporations expand in‑house NGS capabilities to protect proprietary pipelines.

Europe
European nations leverage strong public research networks and sustainability‑driven policies to promote NGS‑enabled precision breeding, particularly for low‑phosphorus and environmentally friendly traits.

Asia‑Pacific
The region’s extensive arable land and climate challenges drive governmental incentive schemes, fostering partnerships between local seed firms and multinational NGS service providers. Disparities in data infrastructure create pockets of uneven progress, attracting investors to emerging bio‑informatics hubs.

South America
Commodity‑focused agribusinesses in Brazil and Argentina adopt NGS to boost drought resilience and disease resistance, with financing often sourced from export‑driven capital markets.

Middle East & Africa
Harsh environments stimulate interest in heat‑ and salt‑tolerant cultivars. Donor‑funded pilot projects are seeding early‑stage collaborations between regional universities and global sequencing platforms.

REPORT SCOPE

This market research report offers a holistic overview of global and regional markets for the forecast period 2026–2034. It presents accurate and actionable insights based on a blend of primary and secondary research.

Key Coverage Areas:

• ✅ Market Overview

• Global and regional market size (historical & forecast)

• Growth trends and value/volume projections

• ✅ Segmentation Analysis

• By product type or category

• By application or usage area

• By end‑user industry

• By distribution channel (if applicable)

• ✅ Regional Insights

• North America, Europe, Asia‑Pacific, Latin America, Middle East & Africa

• Country‑level data for key markets

• ✅ Competitive Landscape

• Company profiles and market share analysis

• Key strategies: M&A, partnerships, expansions

• Product portfolio and pricing strategies

• ✅ Technology & Innovation

• Emerging technologies and R&D trends

• Automation, digitalization, sustainability initiatives

• Impact of AI, IoT, or other disruptors (where applicable)

• ✅ Market Dynamics

• Key drivers supporting market growth

• Restraints and potential risk factors

• Supply chain trends and challenges

• ✅ Opportunities & Recommendations

• High‑growth segments

• Investment hotspots

• Strategic suggestions for stakeholders

• ✅ Stakeholder Insights

• Target audience includes manufacturers, suppliers, distributors, investors, regulators, and policymakers

Frequently Asked Questions

What is the current market size of NGS in Agrigenomics Market?

The NGS in Agrigenomics Market was valued at USD 820 million in 2025 and is expected to reach USD 1.42 billion by 2034, reflecting a CAGR of approximately 6.5%.

Which key companies operate in NGS in Agrigenomics Market?

Key players include Illumina, Thermo Fisher Scientific, BGI Group, Oxford Nanopore Technologies, Roche Sequencing Solutions, PerkinElmer, Eurofins Genomics, AgriGenomics, GeneArt, AgriBioTech, Pacific Biosciences, and Syngenta Crop Genetics.

What are the key growth drivers?

→ Rising demand for precision breeding through genomic‑guided selection.
→ Advancements in sequencing technology (longer reads, lower costs, pay‑per‑sample models).
→ Increased capital allocation by agricultural biotech firms and supportive regulatory frameworks.
→ Strategic partnerships such as Illumina‑Bayer collaboration accelerating cereal crop improvement.

Which region dominates the market?

North America currently leads the market, driven by a strong research ecosystem, substantial private‑sector investment, and early adoption of high‑throughput sequencing platforms.

What are the emerging trends?

→ Climate‑resilient crop applications using NGS to discover stress‑tolerance alleles.
→ Portable, field‑based genotyping (e.g., Oxford Nanopore MinION) enabling rapid decision‑making.
→ Integration of multi‑omics data for comprehensive breeding pipelines.
→ Cloud‑based analytics and AI‑driven trait prediction accelerating breeding cycles.

📘 Get Full Report Here:
NGS in Agrigenomics Market - View Detailed Research Report

About Intel Market Research

Intel Market Research is a leading provider of strategic intelligence, offering actionable insights in biotechnology, pharmaceuticals, and healthcare infrastructure. Our research capabilities include:

• Real-time competitive benchmarking

• Global clinical trial pipeline monitoring

• Country-specific regulatory and pricing analysis

• Over 500+ healthcare reports annually

Trusted by Fortune 500 companies, our insights empower decision‑makers to drive innovation with confidence.

🌐 Website: https://www.intelmarketresearch.com
📞 Asia‑Pacific: +91 9169164321
🔗 LinkedIn: Follow Us